Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Adaptation and Evaluation of a Tobacco Cessation Program: An Integrated mHealth Approach 04/29/2021 INTERVENTIONAL not-comparable 1,990.75 0 Pembrolizumab and Lenvatinib in Advanced Cervical Cancer 04/29/2021 INTERVENTIONAL not-comparable 1,990.75 0 Female Fertility, Environmental Agents and Stress Oxidant 04/29/2021 OBSERVATIONAL not-comparable 1,990.75 0 Placenta Accreta Spectrum Outcome After Uterine Conservation 04/30/2021 INTERVENTIONAL not-comparable 1,989.75 0 The Impact of Cesarean Scar Defects on the Success of Assisted Human Reproduction 05/03/2021 OBSERVATIONAL not-comparable 1,986.75 0 Effects of an Evening PROtein PrEload on Metabolic Health in Night ShIfT Workers (PROPENSITy) 05/03/2021 INTERVENTIONAL not-comparable 1,986.75 0 Post-Marketing Study of Prucalopride Safety In Pregnancy 05/03/2021 OBSERVATIONAL not-comparable 1,986.75 0 The Effect of Dronabinol on the Acquisition and Consolidation of Trauma-Associated Memories 05/04/2021 INTERVENTIONAL not-comparable 1,985.75 0 Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing IVF-ET 05/04/2021 INTERVENTIONAL not-comparable 1,985.75 0 Treatment to Regress to Normoglycemia in Women with a Recent History of GDM 05/05/2021 INTERVENTIONAL not-comparable 1,984.75 0 Breast Cancer Index (BCI) Registry 05/06/2021 OBSERVATIONAL not-comparable 1,983.75 0 Prospective Evaluation of Topical Almond Oil vs Hydroquinone 05/06/2021 INTERVENTIONAL not-comparable 1,983.75 0 A Study of Intra-operative Imaging in Women With Ovarian Cancer 05/07/2021 INTERVENTIONAL not-comparable 1,982.75 0 Role of CBD in Regulating Meal Time Anxiety in Anorexia Nervosa 05/07/2021 INTERVENTIONAL not-comparable 1,982.75 0 Prospective Assessment of Quality of Life in Patients With Locally Recurrent Breast Cancer and Hyperthermic Radiotherapy 05/07/2021 OBSERVATIONAL not-comparable 1,982.75 0 REDUCE Trial- Reducing Prolapse Recurrence 05/10/2021 INTERVENTIONAL not-comparable 1,979.75 0 A Study of Attention and Memory Processes in Breast Cancer Survivors 05/12/2021 OBSERVATIONAL not-comparable 1,977.75 0 D9319C00001- 1L OC Mono Global RCT 05/13/2021 INTERVENTIONAL not-comparable 1,976.75 0 Vaginal NOTES Hysterectomy Versus Vaginal Hysterectomy 05/14/2021 INTERVENTIONAL not-comparable 1,975.75 0 Indications for Breast Reduction in the Public Health Care System 05/17/2021 OBSERVATIONAL not-comparable 1,972.75 0 Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers 05/18/2021 INTERVENTIONAL not-comparable 1,971.75 0 A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery 05/18/2021 INTERVENTIONAL not-comparable 1,971.75 0 Talazoparib in Advanced Breast Cancer Patients With Homologous Recombinant Deficiency 05/19/2021 INTERVENTIONAL not-comparable 1,970.75 0 Circadian Rhythms in Postmenopausal Women 05/19/2021 INTERVENTIONAL not-comparable 1,970.75 0 Novel Imaging Technique to Assess Gynecologic Cancer 05/19/2021 INTERVENTIONAL not-comparable 1,970.75 0 Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer 05/20/2021 INTERVENTIONAL not-comparable 1,969.75 0 A Shared Decision Making Intervention for Diabetes Prevention in Women With a History of Gestational Diabetes Mellitus 05/24/2021 INTERVENTIONAL not-comparable 1,965.75 0 Efficacy Evaluation of ActiGraft in Secondary Closure of Abdominal Surgical Wound Dehiscence 05/24/2021 INTERVENTIONAL not-comparable 1,965.75 0 Measles and BCG Vaccines for Mother and Child 05/24/2021 INTERVENTIONAL not-comparable 1,965.75 0 Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age. 05/26/2021 OBSERVATIONAL not-comparable 1,963.75 0 Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening 05/27/2021 INTERVENTIONAL not-comparable 1,962.75 0 Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors 05/28/2021 INTERVENTIONAL not-comparable 1,961.75 0 Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer 05/28/2021 INTERVENTIONAL not-comparable 1,961.75 0 Breast Fractionation Study - Standard Versus Investigational Fractionation Trial - Nodal Radiation 06/01/2021 INTERVENTIONAL not-comparable 1,957.75 0 Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden 06/02/2021 INTERVENTIONAL not-comparable 1,956.75 0 FEmale Metabolic Risk and Androgens: an Irish Longitudinal (FEMAIL) Study 06/03/2021 OBSERVATIONAL not-comparable 1,955.75 0 Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer 06/04/2021 INTERVENTIONAL not-comparable 1,954.75 0 All-extremity Exercise During Breast Cancer Chemotherapy 06/04/2021 INTERVENTIONAL not-comparable 1,954.75 0 The AUS-PREDICT Registry for DCIS Patients With DCISionRT Testing 06/08/2021 OBSERVATIONAL not-comparable 1,950.75 0 Assessment of Quality of Life and Treatment Times for Patients With Invasive Type Breast Cancer in Martinique 06/08/2021 OBSERVATIONAL not-comparable 1,950.75 0 Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer 06/08/2021 INTERVENTIONAL not-comparable 1,950.75 0 The Clinical Features and Pregnancy Outcomes of CTD Patients 06/09/2021 OBSERVATIONAL not-comparable 1,949.75 0 Mother-Infant Cohort Study in Malaysia and China 06/09/2021 OBSERVATIONAL not-comparable 1,949.75 0 Intervention to Reduce Exposure to Environmental COntaminant (IRECO) 06/09/2021 INTERVENTIONAL not-comparable 1,949.75 0 APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion 06/09/2021 INTERVENTIONAL not-comparable 1,949.75 0 Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer 06/10/2021 INTERVENTIONAL not-comparable 1,948.75 0 Immunomonitoring of Breast Cancer Patients During Systemic Treatment 06/14/2021 INTERVENTIONAL not-comparable 1,944.75 0 Super Hypofractionated Irradiation for Whole Breast Treatment 06/15/2021 INTERVENTIONAL not-comparable 1,943.75 0 Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening 06/16/2021 OBSERVATIONAL not-comparable 1,942.75 0 Advanced or Recurrent Solid Tumors Treated With SHetA2 06/16/2021 INTERVENTIONAL not-comparable 1,942.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology